Prescription affordability remains one of the biggest barriers to treatment access in the United States. Eli Lilly and Company offers several access and affordability pathways, including manufacturer savings cards, self-pay options, insulin affordability programs, patient assistance resources, coverage support and LillyDirect services.
See What Leading Companies Are Building, Investing In And Selling To Their Customers. Download Sample: https://www.towardshealthcare.com/download-sample/5711
The exact support available depends on the medicine, insurance status and eligibility requirements. Some programs primarily support commercially insured patients, while separate pathways may be available for uninsured patients or eligible Medicare beneficiaries.
Lilly Affordability Programs at a Glance
| Program | Who it may help | Key affordability feature |
|---|---|---|
| Lilly Savings Programs | Eligible patients with specific prescriptions | Manufacturer savings or copay support |
| LillyDirect | Insured and eligible self-pay patients | Savings guidance and transparent pricing |
| Insulin Value Program | Eligible insulin users | $35 or less per month for eligible prescriptions |
| Self-Pay Pharmacy Options | Patients choosing not to use insurance | Lilly-set transparent pricing |
| Patient Assistance Resources | Eligible uninsured or underinsured patients | Potential access at lower or no cost |
| Medicare GLP-1 Bridge | Eligible Medicare Part D patients | Select weight-management medicines for $50/month |
| Coverage & Prior Authorization Support | Eligible LillyDirect patients | Help navigating insurance requirements |
Program availability and eligibility vary by medicine and can change.
1. Lilly Savings Cards and Copay Programs
Lilly offers medicine-specific savings programs that may reduce out-of-pocket costs for eligible patients.
Savings cards are generally designed for patients who:
- Have a valid prescription for the medicine
- Use the medicine for an approved indication
- Meet the program’s eligibility requirements
In general, manufacturer savings cards are primarily available to commercially insured patients and are typically not available to people enrolled in Medicare, Medicaid, Medicare Part D, TRICARE or similar government insurance programs.
How it works
Through LillyDirect, available savings cards may be automatically applied for eligible patients when their prescription is processed.
Pros
- Can reduce patient out-of-pocket costs
- Medicine-specific programs may be easy to access
- Savings may be automatically applied through participating LillyDirect dispensing pharmacies
Limitations
- Not every patient qualifies
- Government-insured patients generally face different eligibility rules
- Savings vary by medicine
2. LillyDirect: Savings, Self-Pay and Prescription Support
LillyDirect is Lilly’s direct-to-patient pharmacy experience for select medicines.
The service works with licensed third-party dispensing pharmacies and provides support around:
- Prescription fulfillment
- Insurance coverage checks
- Savings-program identification
- Prior authorization coordination
- Self-pay options
- Free home delivery for eligible prescriptions
Insurance is not required for all LillyDirect access pathways, although medicine availability and payment options differ by product.
Key benefit
Patients can see their final price before completing checkout, and Lilly states that it sets consistent pricing across its LillyDirect dispensing pharmacy options.
3. Lilly Insulin Value Program
Lilly’s insulin affordability program is one of its most clearly defined access initiatives.
The company states that eligible patients can access their monthly prescription of Lilly insulin for $35 or less.
The program includes:
- An automatic $35 maximum monthly out-of-pocket cost for eligible commercially insured patients at many retail pharmacies
- A downloadable savings card for eligible uninsured patients or people using non-participating pharmacies
- Additional affordability solutions and pricing information
Lilly says patients who need a savings card can answer two questions and immediately download the card.
Why this program matters
Insulin is a long-term medicine for many patients, meaning affordability programs can have a direct impact on:
Treatment adherence + continuity of care + healthcare access
4. Self-Pay Options for Patients Without Insurance
Lilly also provides self-pay options for select medicines.
This can be relevant for patients who:
- Do not have insurance
- Have insurance but choose not to use it
- Are prescribed medicines available through a LillyDirect self-pay pathway
The LillyDirect model provides transparent pricing set by Lilly for eligible self-pay medicines.
However, patients choosing self-pay generally agree not to seek reimbursement from their insurance plan or another third-party payer for that purchase.
5. Obesity-Medicine Savings and Self-Pay Programs
Lilly has expanded affordability options around its obesity treatments, including access through LillyDirect.
The company’s sustainability reporting states that certain self-pay options for obesity medicines were offered at substantial discounts compared with the list price of other incretin medicines for obesity.
Lilly reported that its 2.5 mg and 5 mg single-dose vials were available at a 50% or greater discount compared with the list price of other incretin medicines for obesity.
The company also reported $499 per month pricing for certain 7.5 mg and 10 mg single-dose vial options when specific conditions were met.
Key affordability considerations
For obesity medicines, patients should compare:
- Insurance coverage
- Manufacturer savings eligibility
- Self-pay pricing
- Pharmacy dispensing options
- Prior authorization requirements
6. Medicare GLP-1 Bridge Program
LillyDirect now lists a Medicare GLP-1 Bridge program for eligible adults with Medicare Part D.
The program allows eligible patients to access select prescribed weight-management medicines for $50 per month.
Eligibility generally includes
- Adults aged 18 or older
- Medicare Part D coverage
- A prescription for chronic weight management
- Meeting relevant BMI and clinical criteria
The medicines listed include:
- Foundayo (orforglipron)
- Zepbound (tirzepatide) KwikPen
Eligibility requirements apply, and the program does not guarantee insurance coverage.
7. Prior Authorization and Coverage Support
Affordability is not only about the price of a medicine.
Many patients face delays because insurers require prior authorization before providing coverage.
LillyDirect states that it can help coordinate prior authorization between:
Patient + healthcare provider + insurance company
Patients using a self-pay option do not require insurance prior authorization for that self-pay purchase.
Why this matters
Prior authorization support can potentially reduce administrative complexity and help patients understand:
- Whether a medicine is covered
- Whether insurer approval is required
- What documentation may be needed
- Whether savings or self-pay options are available
8. Lilly Pricing Information and Medicine-Specific Resources
Lilly operates a medicine-pricing information resource that helps U.S. patients understand:
- List prices
- Potential pharmacy costs
- Insurance-related costs
- Available affordability programs
- Medicine-specific support resources
The site currently includes information for medicines such as:
- Mounjaro
- Zepbound
- Humalog
- Trulicity
- Taltz
- Verzenio
- Kisunla
- Omvoh
- Olumiant
Lilly states that some uninsured patients who qualify may be able to obtain medicines at a lower cost or potentially no cost, depending on the applicable program.
Lilly’s Affordability Options Compared
| Affordability pathway | Best suited for | Key data |
|---|---|---|
| Savings card | Eligible commercially insured patients | Savings vary by medicine |
| LillyDirect | Patients seeking access and pricing support | Savings + coverage guidance |
| Insulin Value Program | Eligible Lilly insulin users | $35 or less/month |
| Self-pay option | Uninsured or self-pay patients | Medicine-specific pricing |
| Obesity self-pay options | Eligible obesity-treatment patients | Certain options at $499/month under specified conditions |
| Medicare GLP-1 Bridge | Eligible Medicare Part D patients | $50/month for select medicines |
| Prior authorization support | Patients facing coverage requirements | Coordination support available |
Who Benefits Most From These Programs?
Different patient groups may benefit from different pathways.
Commercially Insured Patients
Potential access to:
- Copay cards
- Manufacturer savings programs
- LillyDirect support
- Insurance and prior authorization guidance
Uninsured Patients
Potential access to:
- Self-pay pricing
- Insulin affordability programs
- Medicine-specific assistance resources
Medicare Patients
Traditional manufacturer copay cards generally have restrictions for government-insured patients.
However, eligible patients may have access to specific pathways such as the Medicare GLP-1 Bridge program for listed weight-management medicines.
Patients Managing Diabetes
Lilly’s insulin initiatives provide one of the clearest affordability benchmarks, with eligible patients potentially accessing Lilly insulin for $35 or less per month.
What Are the Main Advantages and Limitations?
Advantages
- Multiple affordability pathways
- Support for insured and self-pay patients
- $35 insulin affordability option for eligible patients
- Medicine-specific savings programs
- Coverage and prior authorization support
- Direct pharmacy and home-delivery options
- New programs targeting eligible Medicare weight-management patients
Limitations
- Eligibility varies substantially by medicine
- Savings cards often exclude government-insured patients
- Not all medicines are available through every LillyDirect option
- Self-pay pricing can still represent a significant financial burden
- Prior authorization and insurance restrictions may remain barriers
- Programs and prices can change over time
What Should Patients Check Before Choosing a Program?
Patients should compare these five factors:
1. Insurance status
Commercial insurance, Medicare, Medicaid and uninsured status can affect eligibility.
2. Specific medicine
Programs are medicine-specific.
3. Prescription indication
Some savings programs require an on-label prescription.
4. Savings eligibility
Copay-card and assistance requirements differ.
5. Self-pay versus insurance
In some situations, patients may compare their insured out-of-pocket cost with available self-pay pricing.
The best starting point is Lilly’s medicine-specific pricing and affordability resource.
Lilly pricing and affordability information
The Bigger Healthcare Access Strategy
Lilly’s approach combines several affordability mechanisms rather than relying on one program:
Manufacturer savings + insulin affordability + self-pay access + coverage support + pharmacy services + medicine-specific assistance
For healthcare organizations and policymakers, this illustrates how pharmaceutical access strategies are increasingly moving beyond traditional patient-assistance programs.
The focus is shifting toward the complete access journey:
Prescription → insurance verification → prior authorization → savings → pharmacy fulfillment → ongoing treatment
How Towards Healthcare Research & Consulting Can Help
Towards Healthcare Research & Consulting can help healthcare stakeholders track:
- Pharmaceutical affordability programs
- Patient assistance initiatives
- Drug pricing strategies
- Copay and savings programs
- Insurance coverage
- Prior authorization trends
- Medicare and Medicaid access
- Obesity-drug affordability
- Diabetes treatment access
- Competitor patient-support programs
The goal is to understand not only what a medicine costs, but also what patients actually pay and which access barriers affect treatment adoption.
Connect with us for complete guidance or further enquiry at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium